Renaissance Technologies
BIOL

Renaissance Technologies’s Biolase, Inc. BIOL Stock Holding History

Renaissance Technologies’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,388
Closed -$39K – 4368
2023
Q1 		$39K Buy
1,388
+957
+222% +$46.6K ﹤0.01% 3711
2022
Q4 		$28K Buy
431
+243
+129% +$35K ﹤0.01% 3904
2022
Q3 		$46K Buy
188
+6
+3% +$2.4K ﹤0.01% 3779
2022
Q2 		$84K Buy
182
+157
+628% +$86.2K ﹤0.01% 3889
2022
Q1 		$22K Buy
25
+10
+67% +$9.22K ﹤0.01% 4000
2021
Q4 		$15K Sell
15
-571
-97% -$720K ﹤0.01% 3847
2021
Q3 		$936K Sell
586
-7
-1% -$11.4K ﹤0.01% 2584
2021
Q2 		$1.03M Sell
593
-296
-33% -$549K ﹤0.01% 2647
2021
Q1 		$1.87M Buy
889
+817
+1,135% +$2.01M ﹤0.01% 2274
2020
Q4 		$75K Buy
+72
New +$54.9K ﹤0.01% 3289
2020
Q3 		– Sell
-218
Closed -$252K – 3776
2020
Q2 		$252K Buy
218
+193
+772% +$220K ﹤0.01% 3102
2020
Q1 		$24K Buy
25
+16
+178% +$24.9K ﹤0.01% 3367
2019
Q4 		$12K Buy
+9
New +$13.8K ﹤0.01% 3463
2017
Q1 		– Sell
-5
Closed -$83K – 3455
2016
Q4 		$83K Buy
5
+2
+67% +$39.6K ﹤0.01% 3124
2016
Q3 		$62K Buy
+3
New +$53.4K ﹤0.01% 3235

Other funds holding BIOL

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Renaissance Technologies's BIOL Position: Q2 2023 in Review

Renaissance Technologies sold out of Biolase, Inc. (BIOL) in Q2 2023, closing a stake of 1,388 shares — an estimated $39K sold.

Renaissance Technologies first reported a position in BIOL in Q3 2016 and held it in 15 quarters. The position peaked at $1.87M in Q1 2021. 25 funds tracked by Wall St. Rank hold BIOL as of Q2 2023.

  • Renaissance Technologies reported no remaining Biolase, Inc. position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 1,388 Biolase, Inc. shares in Q2 2023, an estimated $39K.
  • Renaissance Technologies first reported a position in Biolase, Inc. in Q3 2016 and held it in 15 quarters.
  • Renaissance Technologies's Biolase, Inc. position peaked at $1.87M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.